Works matching DE "BELIMUMAB"

Results: 320

The use of the EVITA algorithm for clinical assessment of novel agents used in prostate cancer, metastatic melanoma, and systemic lupus erythematosus.

Published in:

European Journal of Clinical Pharmacology, 2014, v. 70, n. 8, p. 983, doi. 10.1007/s00228-014-1698-6

By:

Szucs, Thomas;
Puri, Daniele;
Blank, Patricia

Publication type:

Article

Evaluation of the efficacy and safety of belimumab and telitacicept in patients with systemic lupus erythematosus: results from a retrospective, observational study.

Published in:

Clinical & Experimental Medicine, 2025, v. 25, n. 1, p. 1, doi. 10.1007/s10238-025-01640-z

By:

Feng, Tianxiao;
Zhang, Manyu;
Wang, Jieying;
Li, Yang;
Cui, Yang

Publication type:

Article

Recurrent Palpitation in a Young Man with Systemic Lupus Erythematosus Undergoing Belimumab with Resolution After Switching to Telitacicept.

Published in:

2024

By:

Mai, Yanfen;
Pai, Pearl;
Li, Tao;
Guan, Jing;
Zhang, Lijun;
Huang, Jinxian

Publication type:

Abstract

Unveiling a Novel Trend: Belimumab Amplifies Retinal Microvascular Density Decline in Lupus Nephritis Patients Revealed by Optical Coherence Tomography Angiography.

Published in:

2024

By:

Maitiyaer, Maierhaba;
Li, Peiyi;
Li, Huangdong;
Jiang, Dingwen;
Zhang, Jingyu;
Huang, Wenhui;
Liu, Zhiping;
Yu, Shuilian

Publication type:

Abstract

Efficacy of belimumab monotherapy in high infectious risk patient affected by lupus nephritis.

Published in:

Rheumatology Advances in Practice, 2021, v. 5, n. 1, p. 1, doi. 10.1093/rap/rkab023

By:

D'Alessandro, Roberto;
Gonzalez, Estrella Garcia;
Frediani, Bruno

Publication type:

Article

A case of central nervous system nocardiosis in a patient with lupus treated with belimumab.

Published in:

European Journal of Rheumatology, 2016, v. 3, n. 4, p. 188, doi. 10.5152/eurjrheum.2016.15083

By:

Lai, Richard H. C.;
Kim, Deborah;
Constantinescu, Florina

Publication type:

Article

Improved Health Outcomes in Patients with Systemic Lupus Erythematosus Following Early Belimumab Initiation Without Prior Immunosuppressant Use: A Real-World Descriptive Study.

Published in:

Rheumatology & Therapy, 2024, v. 11, n. 4, p. 947, doi. 10.1007/s40744-024-00675-0

By:

Rubin, Bernard;
Chen, Yan;
Worley, Karen;
Rabideau, Brendan;
Wu, Benson;
Chang, Rose;
DerSarkissian, Maral

Publication type:

Article

Real-World Clinical Outcomes in Belimumab-Treated US African American and Hispanic Patients with Systemic Lupus Erythematosus: A Retrospective, Observational Study.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 2, p. 447, doi. 10.1007/s40744-022-00524-y

By:

Bell, Christopher F.;
Chung, Jake;
Rubin, Bernard

Publication type:

Article

Real-World Effectiveness of Belimumab in Systemic Lupus Erythematosus: A Systematic Literature Review.

Published in:

Rheumatology & Therapy, 2022, v. 9, n. 4, p. 975, doi. 10.1007/s40744-022-00454-9

By:

Huang, Shirley P.;
Snedecor, Sonya J.;
Nanji, Sakina;
Lloyd, Emily;
Bell, Christopher F.

Publication type:

Article

Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study.

Published in:

Rheumatology & Therapy, 2021, v. 8, n. 4, p. 1711, doi. 10.1007/s40744-021-00366-0

By:

Meng, Xianmin;
Wang, Qianqian;
Wu, Shunquan;
Pu, Di;
Zhang, Amber;
Fang, Sun;
Zhou, Xuan;
Lu, Hongzhou

Publication type:

Article

Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 4, p. 949, doi. 10.1007/s40744-020-00243-2

By:

Collins, Christopher E.;
Cortes-Hernández, Josefina;
Garcia, Mercedes A.;
von Kempis, Johannes;
Schwarting, Andreas;
Touma, Zahi;
Kurtinecz, Milena;
Gairy, Kerry

Publication type:

Article

First Real-World Insights into Belimumab Use and Outcomes in Routine Clinical Care of Systemic Lupus Erythematosus in Germany: Results from the OBSErve Germany Study.

Published in:

Rheumatology & Therapy, 2016, v. 3, n. 2, p. 271, doi. 10.1007/s40744-016-0047-x

By:

Schwarting, Andreas;
Schroeder, Johann;
Alexander, Tobias;
Schmalzing, Marc;
Fiehn, Christoph;
Specker, Christof;
Perna, Alessandra;
Cholmakow-Bodechtel, Constanze;
Koscielny, Volker;
Carnarius, Heike

Publication type:

Article

Ten tips in lupus nephritis management.

Published in:

Clinical Kidney Journal, 2025, v. 18, n. 1, p. 1, doi. 10.1093/ckj/sfae376

By:

Teoh, Selene T Y;
Yap, Desmond Y H;
Chan, Tak Mao

Publication type:

Article

Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritis.

Published in:

European Journal of Pediatrics, 2024, v. 183, n. 9, p. 3987, doi. 10.1007/s00431-024-05662-9

By:

Li, Huarong;
Chen, Chaoying;
Yang, Hongxian;
Tu, Juan

Publication type:

Article

Therapies Directed Against B-Cells and Downstream Effectors in Generalized Autoimmune Myasthenia Gravis: Current Status.

Published in:

Drugs, 2019, v. 79, n. 4, p. 353, doi. 10.1007/s40265-019-1065-0

By:

Beecher, Grayson;
Putko, Brendan Nicholas;
Wagner, Amanda Nicole;
Siddiqi, Zaeem Azfer

Publication type:

Article

Belimumab: A Review in Systemic Lupus Erythematosus.

Published in:

Drugs, 2018, v. 78, n. 3, p. 355, doi. 10.1007/s40265-018-0872-z

By:

Blair, Hannah A.;
Duggan, Sean T.

Publication type:

Article

Real-World Effectiveness of Intravenous Belimumab on Clinical Outcomes in Patients With Systemic Lupus Erythematosus in Saudi Arabia: The OBSErve Observational Study.

Published in:

Open Access Rheumatology: Research & Reviews, 2025, v. 17, p. 33, doi. 10.2147/OARRR.S497802

By:

Al-Homood, Ibrahim Abdulrazag;
Almaghlouth, Ibrahim;
Asiri, Alhussain Mohammed;
Hamdy, Hanan;
Alhammad, Ali;
Mustafa, Alaa;
Othman, Mohamed;
Khamashta, Munther;
Elfishawy, Tamer;
Teichman, Lindsey;
Santos, Debora dos;
Queiroz, Juliana Domenico;
Noibi, Saeed

Publication type:

Article

Extrapolation of Adult Efficacy Data to Pediatric Systemic Lupus Erythematosus: Evaluating Similarities in Exposure–Response.

Published in:

Journal of Clinical Pharmacology, 2023, v. 63, n. 1, p. 105, doi. 10.1002/jcph.2139

By:

Balevic, Stephen J.;
Niu, Jing;
Chen, Jianmeng;
Green, Dionna;
McMahon, Ann;
Hornik, Christoph P.;
Schanberg, Laura E.;
Glaser, Rachel;
Gonzalez, Daniel;
Burckart, Gilbert J.

Publication type:

Article

Sequential treatment of rituximab and belimumab in thrombotic thrombocytopenia purpura associated with systemic lupus erythematous: A respective case series and literature review.

Published in:

International Journal of Rheumatic Diseases, 2023, v. 26, n. 5, p. 960, doi. 10.1111/1756-185X.14556

By:

Liu, Jun;
Yan, Mingming;
Wen, Rui;
Li, Jiali

Publication type:

Article

Favorable pregnancy outcomes in two patients with systemic lupus erythematosus treated with belimumab.

Published in:

International Journal of Rheumatic Diseases, 2023, v. 26, n. 1, p. 154, doi. 10.1111/1756-185X.14445

By:

Wei, Si‐Ru;
Zhu, Zhen‐Zhen;
Xu, Jia;
Mo, Han‐You

Publication type:

Article

What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary.

Published in:: International Journal of Rheumatic Diseases, 2021, v. 24, n. 10, p. 1331, doi. 10.1111/1756-185X.14214
Publication type:: Article

Belimumab: targeted therapy for lupus.

Published in:

International Journal of Rheumatic Diseases, 2013, v. 16, n. 1, p. 4, doi. 10.1111/1756-185x.12002

By:

Chugh, Preeta K.;
Kalra, Bhupinder S.

Publication type:

Article

Biomarkers for systemic lupus erythematosus.

Published in:

International Journal of Rheumatic Diseases, 2012, v. 15, n. 5, p. 433, doi. 10.1111/j.1756-185X.2012.01764.x

By:

Herbst, Ronald;
Liu, Zheng;
Jallal, Bahija;
Yao, Yihong

Publication type:

Article

2.6 Systemic lupus erythematosus, Sjogren's and antiphospholipid syndrome - therapies.

Published in:: International Journal of Rheumatic Diseases, 2012, v. 15, p. 73, doi. 10.1111/j.1756-185X.2012.01786.x
Publication type:: Article

Straight talk with...Joseph Schwartz.

Published in:

Nature Medicine, 2012, v. 18, n. 6, p. 846, doi. 10.1038/nm0612-846

By:

Ratner, Mark

Publication type:

Article

Emerging Therapies for Cutaneous Lupus Erythematosus.

Published in:

Cutis, 2020, v. 105, n. 6, p. 276, doi. 10.12788/cutis.0007

By:

Borucki, Robert;
Werth, Victoria P.

Publication type:

Article

Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients.

Published in:

Medicina (1010660X), 2023, v. 59, n. 8, p. 1362, doi. 10.3390/medicina59081362

By:

Capdevila, O.;
Mitjavila, F.;
Espinosa, G.;
Caminal-Montero, L.;
Marín-Ballvè, A.;
González León, R.;
Castro, A.;
Canora, J.;
Pinilla, B.;
Fonseca, E.;
Ruiz-Irastorza, G.

Publication type:

Article

Treatment selection in the clinical practice of systemic lupus erythematosus: Results from the Kyushu Collagen Disease Network for Systemic Lupus Erythematosus (KCDN-SLE) registry.

Published in:

Modern Rheumatology, 2025, v. 35, n. 1, p. 102, doi. 10.1093/mr/roae058

By:

Masahiro Ayano;
Naoyasu Ueda;
Koji Mishima;
Shun-Ichiro Ota;
Kazuo Kushimoto;
Atsushi Tanaka;
Shotaro Kawano;
Naoya Nishimura;
Yusuke Kashiwado;
Goro Doi;
Tsuyoshi Nakayama;
Ryo Fukumoto;
Tomomi Tsuru;
Midori Suzaki;
Mitsuteru Akahoshi;
Makiko Maekawa;
Aya Omoto;
Hitoshi Tada;
Koichi Akashi;
Takahiko Horiuchi

Publication type:

Article

Real-world efficacy of belimumab in achieving remission or low-disease activity in systemic lupus erythematosus: A retrospective study.

Published in:

Modern Rheumatology, 2024, v. 34, n. 4, p. 732, doi. 10.1093/mr/road078

By:

Yasuhiro Hasegawa;
Yoshiyuki Arinuma;
Hirotomo Asakura;
Risa Shindo;
Kazuma Ino;
Yoshiro Kanayama;
Tomoki Tanaka;
Yu Matsueda;
Tatsuhiko Wada;
Kenji Oku;
Kunihiro Yamaoka

Publication type:

Article

Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses.

Published in:

Modern Rheumatology, 2023, v. 33, n. 4, p. 751, doi. 10.1093/mr/roac076

By:

Jie Zheng;
Jieruo Gu;
Yin Su;
Yang Li;
Xingfu Li;
Cui Xiong;
Hua Cao;
Quasny, Holly;
Chu, Myron;
Curtis, Paula;
DeRose, Kathleen;
Kurrasch, Regina;
Meizlik, Paige;
Roth, David A.;
Fengchun Zhang

Publication type:

Article

Long-term safety and efficacy of belimumab in Japanese patients with SLE: A 7-year open-label continuation study.

Published in:

Modern Rheumatology, 2023, v. 33, n. 1, p. 122, doi. 10.1093/mr/roab125

By:

Yoshiya Tanaka;
Curtis, Paula;
DeRose, Kathleen;
Kurrasch, Regina;
Kyoko Kinoshita;
Rika Tanaka;
Yumi Yamazaki;
Roth, David A.

Publication type:

Article

Organ system improvements in Japanese patients with systemic lupus erythematosus treated with belimumab: A subgroup analysis from a phase 3 randomized placebo-controlled trial.

Published in:

Modern Rheumatology, 2020, v. 30, n. 2, p. 313, doi. 10.1080/14397595.2019.1630897

By:

Yoshiya Tanaka;
Bass, Damon;
Chu, Myron;
Egginton, Sally;
Beulah Ji;
Roth, David

Publication type:

Article

Efficacy and safety of intravenous belimumab in Japanese patients with systemic lupus erythematosus: A subgroup analysis of a phase 3 randomized placebo-controlled trial.

Published in:

Modern Rheumatology, 2019, v. 29, n. 3, p. 452, doi. 10.1080/14397595.2018.1480915

By:

Yoshiya Tanaka;
Damon Bass;
Myron Chu;
Egginton, Sally;
Beulah Ji;
Struemper, Herbert;
Roth, David

Publication type:

Article

The use of belimumab in three cases of refractory lupus nephritis.

Published in:

Internal Medicine Journal, 2023, v. 53, n. 10, p. 1901, doi. 10.1111/imj.16242

By:

Malaweera, Aruni;
Dayan, Sukhpal;
Pellicano, Rebecca;
Hoi, Alberta;
Kitching, A Richard;
Kent, Joanna R.

Publication type:

Article

Safety and Efficacy of Belimumab Plus Standard Therapy for Up to Thirteen Years in Patients With Systemic Lupus Erythematosus.

Published in:

Arthritis & Rheumatology, 2019, v. 71, n. 7, p. 1125, doi. 10.1002/art.40861

By:

Wallace, Daniel J.;
Petri, Michelle;
Fettiplace, James;
Ji, Beulah;
Roth, David A.;
Heath, Amy;
Ginzler, Ellen M.;
Merrill, Joan T.;
Furie, Richard A.;
Stohl, William;
Chatham, W. Winn;
Weinstein, Arthur;
McKay, James D.;
McCune, W. Joseph

Publication type:

Article

Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Randomized Controlled Study.

Published in:

Arthritis & Rheumatology, 2019, v. 71, n. 6, p. 952, doi. 10.1002/art.40802

By:

Jayne, David;
Blockmans, Daniel;
Luqmani, Raashid;
Moiseev, Sergey;
Ji, Beulah;
Green, Yulia;
Hall, Leanne;
Roth, David;
Henderson, Robert B.;
Merkel, Peter A.;
Lozano, Jose Alfaro;
Becker, Heidemarie;
Quiroz, Armando Calvo;
Carette, Simon;
Carrillo‐Vazquez, Sandra;
Cid, María C.;
D'Cruz, David;
Deodhar, Atul;
Flossman, Oliver;
Garibotto, Giacomo

Publication type:

Article

Development and Validation of a Novel Evidence‐Based Lupus Multivariable Outcome Score for Clinical Trials.

Published in:

Arthritis & Rheumatology, 2018, v. 70, n. 9, p. 1450, doi. 10.1002/art.40522

By:

Abrahamowicz, Michal;
Esdaile, John M.;
Ramsey‐Goldman, Rosalind;
Simon, Lee S.;
Strand, Vibeke;
Lipsky, Peter E.

Publication type:

Article

Efficacy and Safety of Subcutaneous Belimumab in Anti–Double‐Stranded DNA–Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.

Published in:

Arthritis & Rheumatology, 2018, v. 70, n. 8, p. 1256, doi. 10.1002/art.40511

By:

Doria, A.;
Fox, N. L.;
Stohl, W.;
Schwarting, A.;
Okada, M.;
Scheinberg, M.;
van Vollenhoven, R.;
Hammer, A. E.;
Groark, J.;
Bass, D.;
Roth, D.;
Gordon, D.

Publication type:

Article

In This Issue.

Published in:: Arthritis & Rheumatology, 2018, v. 70, n. 8, p. 1, doi. 10.1002/art.40279
Publication type:: Article

Long‐Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus.

Published in:

Arthritis & Rheumatology, 2018, v. 70, n. 6, p. 868, doi. 10.1002/art.40439

By:

Furie, Richard A.;
Wallace, Daniel J.;
Aranow, Cynthia;
Fettiplace, James;
Wilson, Barbara;
Mistry, Prafull;
Roth, David A.;
Gordon, David

Publication type:

Article

Editorial: Bench to Bedside—and Back Again: Finding the Goldilocks Zone Within the Scleroderma Universe.

Published in:

2018

By:

Pope, Janet E.;
Lee, Jason J.;
Denton, Christopher P.

Publication type:

Editorial

Belimumab for the Treatment of Early Diffuse Systemic Sclerosis.

Published in:

Arthritis & Rheumatology, 2018, v. 70, n. 2, p. 308, doi. 10.1002/art.40358

By:

Gordon, Jessica K.;
Spiera, Robert F.;
Martyanov, Viktor;
Franks, Jennifer M.;
Wood, Tammara A.;
Whitfield, Michael L.;
Bernstein, Elana J.;
Szymonifka, Jackie;
Magro, Cynthia;
Wildman, Horatio F.

Publication type:

Article

Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.

Published in:

Arthritis & Rheumatology, 2017, v. 69, n. 5, p. 1016, doi. 10.1002/art.40049

By:

Stohl, William;
Schwarting, Andreas;
Okada, Masato;
Scheinberg, Morton;
Doria, Andrea;
Hammer, Anne E.;
Kleoudis, Christi;
Groark, James;
Bass, Damon;
Fox, Norma Lynn;
Roth, David;
Gordon, David

Publication type:

Article

New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA.

Published in:

Arthritis & Rheumatology, 2017, v. 69, n. 3, p. 487, doi. 10.1002/art.40008

By:

Pisetsky, David S.;
Rovin, Brad H.;
Lipsky, Peter E.

Publication type:

Article

Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials.

Published in:

Arthritis & Rheumatology, 2016, v. 68, n. 9, p. 2184, doi. 10.1002/art.39682

By:

van Vollenhoven, Ronald F.;
Petri, Michelle;
Wallace, Daniel J.;
Roth, David A.;
Molta, Charles T.;
Hammer, Anne E.;
Tang, Yongqiang;
Thompson, April

Publication type:

Article

A23: Favorable Response to Belimumab in Childhood-Onset Systemic Lupus Erythematosus.

Published in:

Arthritis & Rheumatology, 2014, v. 66, p. S37, doi. 10.1002/art.38439

By:

Hui-Yuen, Joyce S;
Bermudez-Santiago, Liza Mariel;
Isgro, Josephine;
Eichenfield, Andrew H.;
Starr, Amy J.;
Imundo, Lisa F.;
Askanase, Anca

Publication type:

Article

Reply.

Published in:

Arthritis & Rheumatology, 2014, v. 66, n. 2, p. 480, doi. 10.1002/art.38251

By:

Petri, Michelle A.;
Vollenhoven, Ronald F.;
Buyon, Jill;
Levy, Roger A.;
Navarra, Sandra V.;
Cervera, Ricard;
Zhong, Z. John;
Freimuth, William W.

Publication type:

Article

Population model‐based analysis of the memory B‐cell response following belimumab therapy in the treatment of systemic lupus erythematosus.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 4, p. 462, doi. 10.1002/psp4.12919

By:

Dimelow, Richard;
Gillespie, William R.;
van Maurik, Andre

Publication type:

Article

High expression of B lymphocyte stimulator in lesional keratinocytes of patients with cutaneous lupus erythematosus.

Published in:

Experimental Dermatology, 2018, v. 27, n. 1, p. 95, doi. 10.1111/exd.13419

By:

Wenzel, Joerg;
Landmann, Aysche;
Vorwerk, Gero;
Kuhn, Annegret

Publication type:

Article

Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 622, doi. 10.1002/cpdd.889

By:

Dimelow, Richard;
Ji, Beulah;
Struemper, Herbert

Publication type:

Article